For example, TROY exerted its oncogenic function in glioma through activating nuclear factor kappa B (NF-κB) signaling [17] and increased tumorigenesis in nasopharyngeal carcinoma by suppressing TGFβ signaling [18]. The gene discussed is NFKB1; the disease is nasopharyngeal carcinoma.